Cross-Sectional and Longitudinal Natural History of CLN3 Disease Progression

被引：0
|
作者：
Masten, Margaux C. [1 ]
Vermilion, Jennifer [1 ]
Adams, Heather R. [1 ]
Vierhile, Amy [1 ]
Marshall, Frederick J. [1 ]
Beck, Christopher A. [1 ]
Mink, Jonathan W. [1 ]
Augustine, Erika F. [1 ]
机构：
[1] Univ Rochester, Rochester, NY USA
来源：
ANNALS OF NEUROLOGY | 2020年 / 88卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
134
引用
收藏
页码：S213 / S213
页数：1
相关论文
共 50 条
  • [21] Nature of Batten disease CLN3 protein in brain
    Pullarkat, RK
    Pullarkat, PS
    Morris, GN
    JOURNAL OF NEUROCHEMISTRY, 1997, 69 : S193 - S193
  • [22] Natural History of Progression of Choroideremia (NIGHT) Study: Cross-Sectional Analysis of Baseline Characteristics
    Lam, Byron L.
    Fischer, M. Dominik
    Pennesi, Mark E.
    Sankila, Eeva-Marja Kaarina
    Holz, Frank G.
    MacLaren, Robert E.
    Birch, David G.
    MacDonald, Ian M.
    Hoyng, Carel C. B.
    Black, Graeme
    Bressler, Neil M.
    Tsang, Stephen H.
    Stepien, Kimberly E.
    Ip, Michael S.
    Pavlovic, Vedran
    Girach, Aniz
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2018, 59 (09)
  • [23] Mutations in CLN3 gene responsible of Batten disease
    Milà, M
    Mallolas, J
    Pineda, M
    Ferrer, I
    Vernet, A
    Badenas, C
    Sánchez, A
    Ballesta, F
    EUROPEAN JOURNAL OF HUMAN GENETICS, 1998, 6 : 145 - 145
  • [24] A cross-sectional natural history study of aspartylglucosaminuria
    Goodspeed, Kimberly
    Edgar, Veronica Bordes
    Horton, Daniel
    Lowden, Andrea
    Sguina, Peter
    Booth, Tim
    Wang, Jerry
    MOLECULAR GENETICS AND METABOLISM, 2022, 135 (02) : S49 - S50
  • [25] Unbiased phenotypic drug screen for CLN3 disease
    Honeybun, Llinos
    Waller-Evans, Helen
    Lloyd-Evans, Emyr
    MOLECULAR GENETICS AND METABOLISM, 2023, 138 (02) : 61 - 61
  • [26] Cross-sectional observations on the natural history of asthma
    Neville, RG
    McCowan, C
    Hoskins, G
    Thomas, G
    BRITISH JOURNAL OF GENERAL PRACTICE, 2001, 51 (466): : 361 - 365
  • [27] Spectrum of mutations in the Batten disease gene, CLN3
    Munroe, PB
    Mitchison, HM
    ORawe, AM
    Anderson, JW
    Boustany, RM
    Lerner, TJ
    Taschner, PEM
    deVos, N
    Breuning, MH
    Gardiner, RM
    Mole, SE
    AMERICAN JOURNAL OF HUMAN GENETICS, 1997, 61 (02) : 310 - 316
  • [28] Exogenous Galactosylceramide as Potential Treatment for CLN3 Disease
    El-Sitt, Sally
    Soueid, Jihane
    Maalouf, Katia
    Makhoul, Nadine
    Al Ali, Jamal
    Makoukji, Joelle
    Asser, Bilal
    Daou, Daniel
    Harati, Hayat
    Boustany, Rose-Mary
    ANNALS OF NEUROLOGY, 2019, 86 (05) : 729 - 742
  • [29] Collaborative plasma biomarkers for Parkinson disease development and progression: A cross-sectional and longitudinal study
    Jiao, Yang
    Zhu, Xue
    Zhou, Xinyi
    Li, Yuanyuan
    Zhou, Liche
    Zhao, Aonan
    Luo, Ningdi
    Niu, Mengyue
    Liu, Jun
    EUROPEAN JOURNAL OF NEUROLOGY, 2023, 30 (10) : 3090 - 3097
  • [30] Methods for quantitative gait analysis in CLN3 disease
    Zimmerman, Grace
    Vierhile, Amy
    Adams, Heather
    Mink, Jonathan
    Augustine, Erika
    MOLECULAR GENETICS AND METABOLISM, 2020, 129 (02) : S166 - S166
12345